Microbial diversity, otitis media, and the pneumococcal transctiptome
微生物多样性、中耳炎和肺炎球菌转录组
基本信息
- 批准号:8205562
- 负责人:
- 金额:$ 24.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-01 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:3 year oldAcuteAge-YearsAntibioticsBacteriaBiodiversityBioinformaticsBiological Response Modifier TherapyBiologyCell LineChildChildhoodClinicalComplexCross-Sectional StudiesDataDetectionDevelopmentDiseaseEpithelial CellsGenesGenomeHaemophilus influenzaeHealthHumanIncidenceInfectionInvadedLeadMeningitisMethodologyMethodsMinorMonitorNIH Program AnnouncementsNational Institute on Deafness and Other Communication DisordersNoseOtitis MediaOutcomePathway interactionsPatternPhiladelphiaPneumococcal 7-Valent Conjugate VaccinePneumococcal ColonizationPneumoniaPrevention strategyPreventiveProbioticsProcessProtocols documentationRNARNA SequencesRelative (related person)ResearchRespiratory SystemRespiratory tract structureRiskSamplingSeasonsSignal TransductionSiteStimulusStreptococcus pneumoniaeStructureStructure of mucous membrane of noseTaxonTherapeuticTissuesTranscriptUpper Respiratory InfectionsUpper respiratory tractViral Respiratory Tract InfectionVirulencecDNA Librarydesigneffective therapyinsightmembermicrobialmicrobial communitynovelnovel strategiesnovel vaccinespathogenrRNA Genesresiliencerespiratory virusresponsetheoriestreatment strategyvaccination strategy
项目摘要
DESCRIPTION (provided by applicant): Streptococcus pneumoniae asymptomatically colonizes the upper respiratory tract of healthy young children and is a leading cause of acute otitis media (OM). S. pneumoniae colonization is a critical step in the disease process and occurs in the context of a complex microbial community. Limited understanding of the relationships between bacterial colonization patterns and risk of OM has hindered the development of preventive and therapeutic strategies that maximize clinical outcomes and minimize disruptions to the protective commensal flora. Our proposed studies are in direct response to the NIDCD Program Announcement (PA-08-092) "Novel Approaches to Study Polymicrobial Diseases". We will analyze pre-existing data from a cross sectional study of 249 Philadelphia children 6 months to =3 years of age. Samples and data were collected during the 2009-10 winter respiratory virus season. High throughput 454 16S rRNA gene pyrosequencing will be used to characterize nasal microbial communities. RNA-sequencing (RNA-seq) on the Illumina Genome Analyzer 2 platform will be used to compare S. pneumoniae transcriptional profiles under a range of experimental conditions. Our specific aims are: 1) To characterize upper respiratory tract microbial community structure in a cross sectional sample of healthy children, children with acute OM, and children with other, primarily non-bacterial upper respiratory tract infections, which often precede the onset of acute OM and 2) To develop RNA- seq protocols and bioinformatics pipelines to study S. pneumoniae transcriptional profiles, alone and in the presence of key commensal species. These studies will identify members of the normal flora involved in the causal pathogenic pathway of S. pneumoniae colonization and acute OM. New methods will be developed to identify S. pneumoniae virulence genes uniquely expressed in polymicrobial settings. Over the long term these data will aid in the development of biotherapeutics such as probiotics and will also provide information relevant for the control of other bacterial pathogens that colonize the respiratory tract.
PUBLIC HEALTH RELEVANCE: This research will elucidate relationships among upper respiratory tract microbial community composition and risk of pneumococcal colonization and otitis media. Results will facilitate development of prevention strategies for common bacterial pathogens.
描述(由申请人提供):肺炎链球菌无疑地在健康幼儿的上呼吸道上定居,并且是急性中耳炎培养基(OM)的主要原因。肺炎链球菌定植是疾病过程中的关键一步,发生在复杂的微生物群落的背景下。对细菌定植模式和OM风险之间关系的了解有限,阻碍了预防和治疗策略的发展,这些策略最大程度地提高了临床结果并最大程度地减少了对保护性共生菌群的干扰。我们提出的研究直接回应了NIDCD计划公告(PA-08-092)“研究多虫病疾病的新方法”。我们将分析来自249名费城儿童6个月至= 3岁的费城儿童的横断面研究中存在的数据。在2009-10冬季呼吸道病毒季节收集了样品和数据。高吞吐量454 16S rRNA基因pyrosequencing将用于表征鼻微生物群落。 Illumina Genome Analyzer 2平台上的RNA测序(RNA-SEQ)将用于比较一系列实验条件下的肺炎链球菌转录曲线。 Our specific aims are: 1) To characterize upper respiratory tract microbial community structure in a cross sectional sample of healthy children, children with acute OM, and children with other, primarily non-bacterial upper respiratory tract infections, which often precede the onset of acute OM and 2) To develop RNA- seq protocols and bioinformatics pipelines to study S. pneumoniae transcriptional profiles, alone and in the presence of key commensal 物种。这些研究将确定与肺炎链球菌定植和急性OM的因果致病途径有关的正常植物群的成员。将开发新的方法来鉴定在多数型环境中唯一表达的肺炎链球菌毒力基因。从长远来看,这些数据将有助于开发益生菌等生物治疗剂,还将提供有关控制呼吸道的其他细菌病原体有关的信息。
公共卫生相关性:这项研究将阐明上呼吸道微生物群落组成以及肺炎球菌定植和中耳炎的风险之间的关系。结果将有助于开发常见细菌病原体的预防策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Melinda Mary Pettigrew其他文献
Melinda Mary Pettigrew的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Melinda Mary Pettigrew', 18)}}的其他基金
Microbial diversity, otitis media, and the pneumococcal transctiptome
微生物多样性、中耳炎和肺炎球菌转录组
- 批准号:
8290218 - 财政年份:2011
- 资助金额:
$ 24.83万 - 项目类别:
Molecular epidemiologic identification of pneumococcal tissue specific genes
肺炎球菌组织特异性基因的分子流行病学鉴定
- 批准号:
7587469 - 财政年份:2007
- 资助金额:
$ 24.83万 - 项目类别:
Molecular epidemiologic identification of pneumococcal tissue specific genes
肺炎球菌组织特异性基因的分子流行病学鉴定
- 批准号:
7383925 - 财政年份:2007
- 资助金额:
$ 24.83万 - 项目类别:
Molecular epidemiologic identification of pneumococcal tissue specific genes
肺炎球菌组织特异性基因的分子流行病学鉴定
- 批准号:
7777360 - 财政年份:2007
- 资助金额:
$ 24.83万 - 项目类别:
Molecular epidemiologic identification of pneumococcal tissue specific genes
肺炎球菌组织特异性基因的分子流行病学鉴定
- 批准号:
7263736 - 财政年份:2007
- 资助金额:
$ 24.83万 - 项目类别:
相似国自然基金
用于急性出血控制的硅酸钙复合海绵的构建及其促凝血性能和机制研究
- 批准号:32301097
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
AF9通过ARRB2-MRGPRB2介导肠固有肥大细胞活化促进重症急性胰腺炎发生MOF的研究
- 批准号:82300739
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
代谢工程化MSC胞外囊泡靶向调控巨噬细胞线粒体动力学改善急性肾损伤的作用及机制研究
- 批准号:32371426
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
- 批准号:82360379
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
超声射频信号神经回路策略模型定量肌肉脂肪化评估慢加急性肝衰竭预后
- 批准号:82302221
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
An Evaluation of Treatment with Omalizumab to Improve the Asthmatic Response to a
奥马珠单抗治疗改善哮喘反应的评估
- 批准号:
8522153 - 财政年份:2012
- 资助金额:
$ 24.83万 - 项目类别:
An Evaluation of Treatment with Omalizumab to Improve the Asthmatic Response to a
奥马珠单抗治疗改善哮喘反应的评估
- 批准号:
8706026 - 财政年份:2012
- 资助金额:
$ 24.83万 - 项目类别:
An Evaluation of Treatment with Omalizumab to Improve the Asthmatic Response to a
奥马珠单抗治疗改善哮喘反应的评估
- 批准号:
8332470 - 财政年份:2012
- 资助金额:
$ 24.83万 - 项目类别:
Microbial diversity, otitis media, and the pneumococcal transctiptome
微生物多样性、中耳炎和肺炎球菌转录组
- 批准号:
8290218 - 财政年份:2011
- 资助金额:
$ 24.83万 - 项目类别:
Fibrous-Hydrogel Composites for Cartilage Repair in an Osteoarthritic Environment
用于骨关节炎环境中软骨修复的纤维水凝胶复合材料
- 批准号:
8197972 - 财政年份:2010
- 资助金额:
$ 24.83万 - 项目类别: